NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...
View the agent price guide.
India Today on MSN10h
104 Indians deported from US: What happens next?In a significant development, the first U.S. military aircraft carrying 104 deported Indian nationals landed in Amritsar on ...
2-Year U.S. Treasury Note Continuous Contract $102.734-0.129-0.13% 5-Year U.S. Treasury Note Continuous Contract $106.484-0.250-0.23% 10-Year U.S. Treasury Note Continuous Contract $109.266-0.313 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback